Their results suggested that FXa-PAR2 signaling in the intestinal epithelium is an important factor in the regulation of postprandial glucose-dependent insulinotropic polypeptide (GIP) and early onset obesity. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.